Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Trial on Statins for Cirrhosis Won't End Debate Anytime Soon

(MedPage Today) -- Statin therapy delivered a statistical near miss at lowering risks of hepatic decompensation and liver cancer in patients with compensated cirrhosis, the phase III SACRED trial showed. In an intention-to-treat analysis, 8.97...

Trial on Statins for Cirrhosis Won't End Debate Anytime Soon

We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.

Read the original at medpagetoday.com →

More in Health & Medicine

More from Friday 13 November →